BeOne Medicines Ltd Earnings Dividend

BeOne Medicines Ltd’s revenue jumped 32.84% since last year same period to $1498.17Mn in the Q4 2025. On a quarterly growth basis, BeOne Medicines Ltd has generated 6.08% jump in its revenue since last 3-months.

BeOne Medicines Ltd’s net profit jumped 143.79% since last year same period to $66.5Mn in the Q4 2025. On a quarterly growth basis, BeOne Medicines Ltd has generated -46.73% fall in its net profits since last 3-months.

BeOne Medicines Ltd’s net profit margin jumped 132.96% since last year same period to 4.44% in the Q4 2025. On a quarterly growth basis, BeOne Medicines Ltd has generated -49.78% fall in its net profit margins since last 3-months.

BeOne Medicines Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.79 - a -48.65% fall from last quarter’s estimates.

BeOne Medicines Ltd’s earning per share (EPS) estimates for the current year stand at 0.79.

BeOne Medicines Ltd’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the BeOne Medicines Ltd has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.